based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing biologics She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience

We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist , systems and synthetic biologist, technologist, heavy CRISPR user, protein sequence- and structure-based

She has worked across pharmaceutical, biotechnology, and academic settings, including a research placement therapies Obligatory receptor heterodimers and the limits of current characterization tools Structural biology as prerequisites for meaningful GPCR pharmacology Career navigation across academia, big pharma, and biotech up to 20% of women worldwide, Hay notes, the research investment in understanding the receptor-level biology

Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical Biology

He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr.

Bender uses virtual docking to find chemical probes for orphan GPCRs - receptors biology can't study GUEST Bender is a postdoctoral fellow at UCSF working at the intersection of computational structural biology He trained as a structural biologist at Vanderbilt University, working with X-ray crystallography, protein Bender's work targets this gap directly - arguing that de-orphanizing a receptor biochemically and making They may vary slightly from the final edited version. 00:00 Introduction 01:31 From structural biology

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Alejandra Tomas is a molecular cell biologist and Senior Lecturer at the Department of Metabolism, Digestion She obtained a PhD in Biochemistry from University College London and spent several years in Switzerland

co-founder of Propel Careers, has spent more than a decade coaching PhDs and postdocs and recruiting for biotech CEO and co-founder of Propel Careers, a Boston-based firm that coaches scientists and recruits for biotech and research institutions on resumes, negotiation, informational interviewing, and the mechanics of biotech Function over title Job titles in biotech are often creative and inconsistent — a medical science liaison scientists undervalue 14:16 The informational interview — permission granted 23:57 The COVID shift in biotech

In addition, I generated various optical biosensors based on fluorescence or bioluminescence resonance

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

trafficking and recycling, and more recently the cannabinoid entourage hypothesis — combining BRET-based biosensors receptor tone Quantitative pharmacology as rescue operation — using operational models and BRET-based biosensors mechanistic story that guided a decade of biased-ligand drug discovery needs rebuilding from the underlying biology

Adriano Marchese Adriano Marchese is a Professor of Biochemistry at the Medical College of Wisconsin.

Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's group as a bioinformatician.

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain and Belgium, and subsequently as a cell biologist during my postdoc (2006-2011) with Dr. Marilyn Farquhar (UC, San Diego), a pioneer of modern Cell Biology. To achieve this goal, we use a wide range of established approaches (biochemistry, cell biology, genetics purified proteins, cultured cells, model organisms) in combination with the development of novel tools (biosensors

Moro, that he truly saw how molecules could go beyond the bench and interact with biology in powerful The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t static—they could act , bind , and modulate biological targets. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

Ilana uses chemical biology-based methods to study the regulation and protein-protein interactions of Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

podcast list Strategic Partner(s) Gáspár Pándy-Szekeres About Gáspár Pándy-Szekeres " After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's group as a bioinformatician.

activation mechanism of this family of G protein-coupled receptors using innovative approaches, including biosensors

Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Neuroscience, and Artificial Intelligence and Human Health, as well as the Dean of The Graduate School of Biomedical To this end, her lab uses several computational structural biology tools and rational drug design approaches , ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy in Computational Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics

GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology

joined in April 2020, following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology. Katarzyna handles submissions in structural biology, biophysics and biochemistry, with a particular focus

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Sri Kosuri Sri is a biologist that has helped build technologies, labs, and companies in synthetic biology , functional genomics, and bioinformatics over the last 20 years. He is passionate about developing more rational ways to understand and engineer biology. , human genetic variation, gene regulation, chemical biology, synthetic biology, and functional genomics at MIT and BS in Bioengineering at UC Berkeley.

I’m currently a senior scientist at a biotech in Toronto, Canada. to biology started. I was always interested in biology, especially studying anatomy. At the time, I didn’t realize the full scope of GPCR biology. When I saw that bioinformatics combined biology and computing, I knew immediately that this was what